Merck & Co., Inc.
MRK
$93.19
$0.630.68%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 15.62B | 16.66B | 16.11B | 15.78B | 14.63B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 15.62B | 16.66B | 16.11B | 15.78B | 14.63B |
| Cost of Revenue | 3.71B | 3.89B | 3.68B | 3.42B | 3.80B |
| Gross Profit | 11.92B | 12.77B | 12.43B | 12.35B | 10.84B |
| SG&A Expenses | 2.69B | 2.54B | 2.55B | 2.32B | 2.64B |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 10.28B | 12.29B | 9.10B | 9.08B | 15.28B |
| Operating Income | 5.34B | 4.36B | 7.02B | 6.70B | -654.00M |
| Income Before Tax | 4.17B | 4.09B | 6.01B | 5.67B | -2.05B |
| Income Tax Expenses | 426.00M | 929.00M | 545.00M | 903.00M | -820.00M |
| Earnings from Continuing Operations | 3.74B | 3.16B | 5.46B | 4.77B | -1.23B |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -1.00M | -4.00M | -6.00M | -5.00M | 0.00 |
| Net Income | 3.74B | 3.16B | 5.46B | 4.76B | -1.23B |
| EBIT | 5.34B | 4.36B | 7.02B | 6.70B | -654.00M |
| EBITDA | 6.46B | 5.51B | 8.08B | 7.62B | 249.00M |
| EPS Basic | 1.48 | 1.25 | 2.15 | 1.88 | -0.48 |
| Normalized Basic EPS | 1.24 | 1.08 | 1.67 | 1.58 | -0.24 |
| EPS Diluted | 1.48 | 1.24 | 2.14 | 1.87 | -0.48 |
| Normalized Diluted EPS | 1.24 | 1.08 | 1.66 | 1.58 | -0.24 |
| Average Basic Shares Outstanding | 2.54B | 2.53B | 2.53B | 2.53B | 2.53B |
| Average Diluted Shares Outstanding | 2.54B | 2.54B | 2.54B | 2.54B | 2.53B |
| Dividend Per Share | 0.77 | 0.77 | 0.77 | 0.77 | 0.73 |
| Payout Ratio | 52.12% | 61.86% | 36.41% | 40.95% | -151.06% |
